Evaluation of cardiovascular risk biomarkers after moderate consumption of red wine and cachaça in a randomized crossover trial: The Wine and Cachaça Study (WICAS)

• Published in: Clinical nutrition ESPEN Vol. 52; pp. 113 - 118
• Main Authors: Henrique de Moraes Cellia, Pedro, Lima, Eduardo Gomes, Agrizzi de Angeli, Luiz Renato, Martins, Eduardo Bello, Rached, Fabiana Hanna, Pitta, Fabio Gruspun, Cassaro Strunz, Celia Maria, Serrano Jr, Carlos Vicente
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.12.2022
• Subjects: Adult; Alcohol; Atherosclerosis; Biomarkers; Cachaça; Cardiovascular Diseases; Cardiovascular risk; Cross-Over Studies; Female; Gastroenterology and Hepatology; Heart Disease Risk Factors; Humans; Internal Medicine; Male; Middle Aged; Prospective Studies; Risk Factors; Weight Gain; Wine; Wine - analysis; Wine; Alcohol; Cachaça; Atherosclerosis; Cardiovascular risk; alcohol; cachaça; cardiovascular risk
• ISSN: 2405-4577; 2405-4577
• DOI: 10.1016/j.clnesp.2022.10.014

Moderate daily consumption of alcohol (MDCA) is associated with cardiovascular risk (CVR) reduction in observational studies. Some researches have suggested that this benefit may be associated not only with red wine consumption but also with other beverages. However, there are no clinical trials evaluating the possible CVR benefit of Brazilian spirit (cachaça) in humans. This is a prospective, randomized, crossover study including healthy individuals initially assigned to a MDCA of cachaça or red wine for a period of 4 weeks. After a one-week abstinence period, the type of drink was changed for another 4 weeks of intervention. The MDCA for both beverages was determined as a dose equivalent to 28 g of ethanol per day for men and 14 g for women. CVR biomarkers analyses were performed before and after each intervention to assess the serologic status of C-reactive protein, lipid profile, platelet aggregation and glycemic profile. This study is registered on the ISRCTN platform under number 15978506. Of the 42 subjects initially randomized, 2 refused to continue in the study. The median age was 44.3 ± 10.3 years and 19 were male (47.5%). Adherence to the protocol was considered ideal with 100% regular use in both interventions and only 3 individuals in each intervention group reported alcohol abuse. There was no significant variation in anthropometric measurements during the study, except for weight gain (0.7 kg) in the red wine group (p = 0.005). The median of the delta of platelet aggregation for MDCA of cachaça was 1.2% (−1.1 to 5.3) and the median of the delta to the MDCA of wine was −1.6% (−4.5 to 2) (p = 0.02). The other biomarkers didn't show any statistically significant variation. Moderate consumption of wine and cachaça was related to variation in laboratory biomarkers of CVR related to atherosclerosis. There was significant weight gain during the period of wine consumption and there was observed a difference between platelet aggregation values after both interventions.